The renoprotective effect of once‐weekly GLP‐1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67)

AIMS/INTRODUCTION: Few studies have investigated the renoprotective effect of glucagon‐like peptide‐1 (GLP‐1) receptor in patients with chronic kidney disease (CKD). This study evaluated the effect of dulaglutide 0.75 mg on renal function in Japanese patients with type 2 diabetes and CKD stage 3 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuchida, Ken‐ichi, Taneda, Shinji, Yokota, Isao, Okada, Kazufumi, Kurihara, Yoshio, Yokoyama, Hiroki, Iwamoto, Masahiro, Yamazaki, Katsuya, Ishigaki, Yasushi, Manda, Naoki, Maegawa, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623516/
https://www.ncbi.nlm.nih.gov/pubmed/35735780
http://dx.doi.org/10.1111/jdi.13877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623516/
https://www.ncbi.nlm.nih.gov/pubmed/35735780
http://dx.doi.org/10.1111/jdi.13877

Ejemplares similares